With the objective to develop supramolecular catalysts for useful chemical transformations, we report here a rapid and efficient solid-phase synthesis of novel cyclic dipeptides (crown-CDPs) with a diversity of L-DOPA derived crown ether substituents and stereochemistry. We prepared and characterized 14 crown-CDPs and evaluated their efficiency as supramolecular epoxidation catalysts in a water/hexanes biphasic system. Yields increase significantly in the presence of the crown-CDPs, though enantioselectivity depends on the nature of the substituents. The results reported constitute a useful approach for chiral epoxides of interest and further illustrate the potential of cyclic peptides as supramolecular catalysts.
Introduction
Cyclic dipeptides (CDPs) are an excellent, easily accessible scaffold for producing supramolecular receptors and catalysts. [1] [2] [3] [4] [5] [6] [7] [8] [9] CDPs have two chiral side chains on a flat cyclic dipeptide ring, which allows a rich diversity of substituents to be added with a preferential orientation. We recently reported an example of interfacial supramolecular catalysis, the asymmetric epoxidation of electron-deficient ketones catalysed by several CDPs in a water/hexanes media. 10, 11 Good enantioselectivities were obtained, though conversions were good to moderate after 48 h.
We also demonstrated that some structural features are required for efficient conversion and, more importantly, induction of chirality into the products. Very subtle changes in the CDPs can lead to significant drops in efficiency. Among all the CDPs prepared, the most efficient one was derived from L-Leucine, leading to 70% ee in the epoxidation process.
Computational studies provided insight into the functional supramolecular interfacial complex between cyclo(L-Leu-L-Leu), the enone, a sodium cation and a hydroperoxide ion, which is required for good enantioselectivity, consistent with the experimental data. 11 Thus, the well-defined supramolecular complex located at the interface with a cation inspired us to develop a second generation of CDP catalysts. We hypothesized that incorporating one or two crown ethers as cation ligands onto the cyclic dipeptide core could enhance both reaction rate and enantioselectivity, thus acting as supramolecular phasetransfer catalysts. Crown ethers are well known phase-transfer catalysts used efficiently in numerous processes. 12 Interestingly, Bakó et al. reported the use of monoaza- [15] -crown-5
derived from monosaccharides as an asymmetric phase-transfer catalyst in the epoxidation of electron-deficient enones [13] [14] [15] [16] [17] and other further theoretical studies have been described. 18 Also, chiral crown ethers have been examined for asymmetric phase-transfer epoxidation of olefins. 19, 20 Herein, we report our results on the efficiency of mono-and bis-L-DOPA derived crown ether cyclic dipeptides (crown-CDPs) using different oxidant systems.
Early examples of similar crown-CDPs were reported by Sonveaux et al. In their studies, five crown-CDPs were prepared in solution by the condensation of one N-Boc protected amino acid and a crown DOPA methyl ester. 21, 22 A further cyclization step of the linear dipeptide in solution led to cis (1-2), trans (3) (4) and bis (5) crown-CDPs, as depicted in Figure 1 . Also, Závada et al. synthesized three crown-CDPs (6-8) with a spiro-crown ether attached to the α-carbons ( Figure 1 ). 23 Our strategy to prepare crown-CDPs with one crown ether side chain involved using one proteogenic amino acid and one L-DOPA-derived crown ether. We use leucine, alanine and phenylalanine, based on our previous results. 11 In addition, we investigated crown-CDPs with two crown ether side chains in an attempt to exploit a cooperative binding of metal cations, which in turn could facilitate the migration of the hydroperoxide anion at the interface. This could lead to an increase of the epoxidation reaction rate and enantioselectivity.
Recently, we reported a rapid and efficient parallel synthetic procedure toward optically pure CDPs, using enantiopure N-t-butyloxycarbonyl (N-Boc) protected amino acids. 11, 24 We used a Kaiser oxime resin with an N-Boc protection strategy to prepare linear dipeptides, which were cleaved from the resin by an intramolecular cyclization to yield highly pure CDPs. Using this synthetic strategy, we report herein the preparation of novel enantiopure crown-CDPs bearing one or two crown ether side chains and their utilization as asymmetric supramolecular catalysts in the epoxidation of electron-deficient ketones.
Results and discussion

Crown ether amino acids synthesis
The binding selectivity of crown ethers depends on their size and on the number of oxygen atoms each contains. Hence, we devised a general synthetic strategy for enantiopure crown ether amino acids with different macrocycle sizes. 25 The synthetic procedure starts with commercially available 3,4-dihydroxy-L-phenylalanine, L-DOPA (9) . Taking advantage of the catechol function, macrocycles were formed in solution from fully protected L-DOPA 11 and dibromo-oligo(ethylene glycol) synthons 12-14, leading to a variety of crown ether amino acids 15-17 ( Figure 2 ). The acid function was then deprotected using NaOH in methanol to provide the desired N-Boc protected amino acids 18-20, which were used in peptide synthesis. Overall, the N-Boc crown ether L-phenylalanines 18, 19 and 20 were prepared in five steps with respectively 35%, 42% and 53% isolated yields from L-DOPA.
The crown ethers were optically pure, as established previously. 26 
Cyclic dipeptide synthesis
Fourteen new crown-CDPs were prepared by solid-phase synthesis using Kaiser oxime resin. 27, 28 Taking advantage of the availability of natural and unnatural chiral amino acids as chiral synthons, the crown-CDPs were synthesized with a variety of substituents and stereochemistry. The key step of this rapid method is the concomitant cyclization and cleavage of a linear dipeptide from the oxime ester linkage from resin, as previously reported. 10, 11, 24, 29, 30 The first amino acid was coupled for three hours using diisopropylcarbodiimide (DIC) as a coupling reagent. The N-Boc protecting group was removed using a mixture of 1:1 trifluoroacetic acid (TFA)/dichloromethane, while the second amino acid was activated with 6-Chloro-1-hydroxybenzotriazole (6-Cl-HOBt) and
O-(6-Chlorobenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
(HCTU). After deprotection, the linear dipeptide was treated with diisopropylethylamine (DIEA; 2.5 equiv.) and acetic acid (AcOH; 5 equiv.) in dichloromethane to cause simultaneous cyclization and cleavage from the resin, leading to high-purity crown-CDPs (Table 1) with control over substitution patterns and the stereochemistry.
21-34
In this way, we successfully synthesized cis and trans analogues of crown-CDPs with a variety of crown ether side chains. We also prepared all possible combinations of crownCDPs bearing two crown ether side chains using N-Boc amino acids 18-20. Overall, 14
crown-CDPs were prepared in good yields (40-81%) with between 80-92% purity by a simple treatment of the crude cyclization products with Amberlite IR-120 and trituration with ether. The purity of all crown-CDPs was sufficient to be used as-is in the epoxidation reactions. It is worth mentioning that the overall synthesis proceeds with very low racemization (5% or less), as measured by NMR signals of the diastereomeric crownCDPs. 24 
Use of crown-CDPs in the epoxidation of electron-deficient enones
Optimization of reaction conditions
With a series of diverse enantiopure crown-CDPs in hand, we investigated their efficacy in the asymmetric epoxidation of a model substrate, the trans-chalcone 35 producing the epoxychalcone 36a. At first, we investigated the epoxidation using cis crown-CDP 21, which has a benzo-18-crown-6 side chain and an isobutyl side chain. The epoxidation of 35 was carried out in a liquid-liquid toluene/water biphasic system employing aqueous sodium hydroxide in 30% hydrogen peroxide as a reagent, with 10 mol% of catalyst 21 ( Table 2, entries 1-2).
These experiments revealed that a higher concentration of sodium hydroperoxide increases the reaction rate. The use of dichloromethane instead of toluene led to a lower yield and provided racemic epoxychalcone 36a ( Table 2 , entry 3). Both diethyl ether and hexanes led to high yields, though only hexanes yielded enantio-enriched 36a, albeit with a low 9% ee ( We then explored the impact of counter cations on the process. Lithium, potassium and cesium ions were investigated ( Table 2 , entries 8-12). The lithium cation was more efficient than other cations in providing epoxychalcone with higher enantioselectivity (37% ee), which replicates a phenomena observed by others. 31, 32 Interestingly, we observed a higher reaction rate at a lower base concentration using lithium hydroxide. This could be due to the ability of the benzo-18-crown-6 to more efficiently bind sodium and potassium ions, hence possibly decreasing the stability of the supramolecular complex necessary for catalysis. In fact, the nature of the counter cation significantly impacts the chemical yield and the enantioselectivity at lower concentrations.
An attempt to enhance the enantioselectivity by lowering the reaction temperature to zero degrees led to a slightly increased enantioselectivity, from 37% to 39% ee of epoxychalcone 36a ( 
Investigation of the efficacy of crown-CDPs prepared
Using the optimized conditions, we investigated the supramolecular catalytic ability of all the crown-CDPs prepared. First, cis crown-CDP-21, bearing isobutyl and benzo-18-crown-6 side chains, provided a higher enantioselectivity of (2R,3S)-epoxychalcone 36a (34%) than the trans diastereoisomer crown-CDP-22 (7%) ( In order to verify the steric impact of side chains in the epoxidation process, further investigations were performed with crown-CDPs bearing a methyl (27) or a benzyl (28) side chain and both having a benzo-18-crown-6 side chain. Using crown-CDPs with methyl or benzyl moieties gave lower enantioselectivities as compared to an isobutyl group (Table   3 , entries 7-8). We also investigated crown-CDPs bearing two different crown ethers. In all cases, regardless of the combination of crown ether side chains, crown-CDP 29-34 yielded epoxychalcone 36a with low enantiomeric excesses (up to 8%).
In general, as reported previously, 11 cis crown-CDPs provided better asymmetric induction than trans crown-CDPs. Moreover, crown-CDPs with only one crown ether side chain were more efficient in asymmetric induction than crown-CDPs bearing crown ethers in the epoxidation process. These results point to the importance of having a higher dissymmetry in the supramolecular catalyst to induce higher enantioselectivity.
Reaction scope using crown-CDP 21
We next investigated the substrate scope of the crown-CDP catalyzed epoxidation under optimal conditions, but using only 5 mol% of CDP-21 for 72 h. Under those conditions, epoxidation of trans-chalcone 35 provided a high yield (93%) and 34% ee of (2R,3S)-epoxide 36a (Table 4 , entry 1). Epoxidation of chalcone with electron-withdrawing chloro group on the β-phenyl moiety led to moderate yield (32%) and 27% ee of (2R,3S)-epoxide 36b ( Table 4 , entry 2).
We also verified the effect of a para-fluoro substitution on the α-phenyl moiety of the chalcone. Reaction with this substrate led to 31% yield and 30% ee of (2R,3S)-epoxide 36c (Table 4 , entry 3). A higher reaction rate was obtained with chalcone having a para-fluoro substitution on the β-phenyl moiety, leading to a good yield (67%). However, a decrease of enantioselectivity to 18% of (2R,3S)-epoxide 36d is observed (Table 4 , entry 4) in that case. Epoxidation of the bi-substituted chalcone 36e led to a good yield (54%) and to the highest enantioselectivity observed in this study, 40% ee of (2R,3S)-epoxide 36e (Table 4, entry 5).
Substitutions at different positions on the β-phenyl moiety with the strong electronwithdrawing nitro group led to variable results (Table 4 , entries 6-8). The yield (81%) and enantioselectivity (21%) are highest in the case of the para-nitro substitution of (2R,3S)-epoxide-36f (Table 4 , entry 6). Yields and enantioselectivities decrease with meta and ortho substitutions leading to 15% and 6% respectively of (2R,3S)-epoxide 36g and (2R,3S)-epoxide 36h. It this case, both electronic and steric effects explain the significant decrease of reactivity. Lower electrophilicity of the enone with a para methoxy electron-donating group on the β-phenyl moiety afforded (2R,3S)-epoxide 36i with a low yield (10%) and enantioselectivity (13%) ( Table 4 , entry 9). On the other hand, using a 2-napthyl substitution on the enone led to a good yield (45%) and low enantiomeric excess (19%) of (2R,3S)-epoxide 36j (Table 4 , entry 10).
In summary, studies with different substrates strongly suggest that both the steric hindrance and electronic factors of chalcones play a crucial role in the outcomes of the process. The level of enantioselectivity observed is highly variable, and seems to rely on many parameters. In all cases, the supramolecular catalysis of crown-CDPs led to (2R,3S)-epoxides, which shows that the same type of supramolecular complex is involved in the catalysis. Though multiple orientations of the substrate are possible, it has been previously demonstrated that in phase-transfer epoxidations, the chiral crown ethers complex the cation, which in turn brings the hydroperoxide anion to the interface for nucleophilic 1,4-addition on the enone. 33 In this study, we demonstrated that incorporating crown-DOPA derivatives into cyclic dipeptides does not improve the efficiency of the supramolecular catalytic epoxidation of electron-deficient enones. The results illustrate the difficulties in designing highly efficient supramolecular catalysts, at least for epoxidation processes.
Conclusion
In 
Experimental section
General information
Oxime resin (1.12 mmol/g), coupling reagents, and N-Boc-protected amino acids were rotations were measured at ambient temperature on a Jasco DIP-360 digital polarimeter using a sodium lamp. Crown amino acids were prepared following reported procedures. 25 Their synthesis and characterization are reported in the SI.
Preparation of crown-CDPs
Coupling of the first N-Boc protected α-amino acid on oxime resin
A desired quantity of oxime resin (1.12 mmol/g) was added to a peptide synthesis vessel.
The resin was treated three times with CH 2 Cl 2 . Amino acid (3.0 equiv.) and 6-Cl-HOBt 
Acetylation of unreacted sites on oxime resin
The resin was treated three times with DMF (3 x 20 mL). A solution of 50% v/v DMF/acetic anhydride (15 mL) and DIEA (1.5 mL) were added to the peptide synthesis vessel and shaken for 1 hour. Then, the mixture was filtered under vacuum and the resin was washed [DMF (3 x 15 mL), MeOH (3 x 15 mL), DMF (3 x 15 mL), MeOH (3 x 15 mL)] and dried under reduced pressure.
Removal of the N-Boc protecting group
The resin was treated three times with CH 2 Cl 2 (15 mL 
Coupling of the second N-Boc protected α-amino acid
The amino acid (3.0 equiv.) was dissolved in DMF in a 100 mL flask. The solution was cooled to 0 °C, then HCTU (3.0 equiv.) and HOBt (3.0 equiv.) were added. The mixture was poured into the peptide synthesis vessel, in which the resin was previously treated with CH 2 Cl 2 . DIEA (6.0 equiv.) was also added to the vessel and the mixture was shaken for 3 h.
After filtration under vacuum, the resin was washed [DMF (3 x 15 mL), MeOH (3 x 15 mL), DMF (3 x 15 mL) and MeOH (3 x 15 mL)] and dried under reduced pressure. The
Kaiser ninhydrin test was performed to monitor the efficiency of the coupling, and the coupling procedure was repeated as needed.
Cyclization/cleavage from the resin
First, the N-Boc group was removed using the procedure described in (4. 
cyclo[D-Leu-L-DOPA(18-C-6)] (22
cyclo[L-Leu-L-DOPA(21-C-7)] (23
cyclo[D-Leu-L-DOPA(21-C-7)] (24
cyclo[L-Leu-L-DOPA(15-C-5)] (25
cyclo[D-Leu-L-DOPA(15-C-5)] (26
cyclo[L-Phe-L-DOPA(18-C-6)] (28
cyclo[L-DOPA(15-C-5)-L-DOPA(18-C-6)] (30)
.
cyclo[L-DOPA(18-C-6)-L-DOPA(18-C-6)] (32
cyclo[L-DOPA(18-C-6)-L-DOPA(21-C-7)] (33
General procedure for epoxidation of unsaturated ketones
The catalyst 
trans-(2R,3S)-Epoxy-1,3-diphenylpropan-1-one 10,34,35 (36a)
The ee of epoxide 36a was determined by HPLC analysis using a Chiralcel OD-H column 10,35,36 (36b) The ee of epoxide 36b was determined by HPLC analysis using a Chiralcel OD-H column 10,35,37 (36c) The ee of epoxide 36c was determined by HPLC analysis using a Chiralcel AD-H column (0.25 cm ⋅ 0.46 cm ID), conditions: λ 254 nm, hexanes/i-PrOH 95/5, flow rate 0.6 mL/min, t R minor (2S,3R) = 33.00 min, t R major (2R,3S) = 35.73 min. 10,35,38 (36d) The ee of epoxide 36d was determined by HPLC analysis using a Chiralcel OD-H column (0.25 cm ⋅ 0.46 cm ID), conditions: λ 254 nm, hexanes/i-PrOH 95/5, flow rate 0.6 mL/min, t R minor (2S,3R) = 18.95 min, t R major (2R,3S) = 20.89 min.
trans-(2R,3S)-Epoxy-3-(4-chlorophenyl)-1-phenyl-1-propan-1-one
trans-(2R,3S)-Epoxy-3-(4-fluorophenyl)-1-phenyl-1-propan-1-one
trans-(2R,3S)-2,3-epoxy-3-phenyl-1-(4-fluorophenyl)propan-1-one
trans-(2R,3S)-2,3-epoxy-1-(4-methylphenyl)-3-(4-fluorophenyl)
propan-1-one 10, 35, 39 (36e)
The ee of epoxide 36e was determined by HPLC analysis using a Chiralcel AD-H column (0.25 cm ⋅ 0.46 cm ID), conditions: λ 254 nm, hexanes/i-PrOH 95/5, flow rate 0.6 mL/min, t R minor (2S,3R) = 38.75 min, t R major (2R,3S) = 42.07 min.
trans-(2R,3S)-Epoxy-3-(4-nitrophenyl)-1-phenyl-1-propan-1-one 10,34,35 (36f)
The ee of epoxide 36g was determined by HPLC analysis using a Chiralcel OD-H column (0.25 cm ⋅ 0.46 cm ID), conditions: λ 254 nm, hexanes/i-PrOH 95/5, flow rate 0.6 mL/min, t R minor (2S,3R) = 61.98 min, t R major (2R,3S) = 67.98 min.
trans-(2R,3S)-Epoxy-3-(3-nitrophenyl)-1-phenyl-1-propan-1-one 10,35 (36g)
The ee of epoxide 36h was determined by HPLC analysis using a Chiralcel OD-H column (0.25 cm ⋅ 0.46 cm ID), conditions: λ 254 nm, hexanes/i-PrOH 95/5, flow rate 0.6 mL/min, t R minor (2S,3R) = 48.75 min, t R major (2R,3S) = 55.02 min.
trans-(2R,3S)-Epoxy-3-(2-nitrophenyl)-1-phenyl-1-propan-1-one 10,35 (36h)
The ee of epoxide 36i was determined by HPLC analysis using a Chiralcel OD-H column (0.25 cm ⋅ 0.46 cm ID), conditions: λ 254 nm, hexanes/i-PrOH 95/5, flow rate 0.6 mL/min, t R major (2R,3S) = 44.55 min, t R minor (2S,3R) = 50.27 min. 10, 35, 36 (36i).
trans-(2R,3S)-Epoxy-3-(4-methoxyphenyl)-1-phenyl-1-propan-1-one
The ee of epoxide 36j was determined by HPLC analysis using a Chiralcel OD-H column (0.25 cm ⋅ 0.46 cm ID), conditions: λ 254 nm, hexanes/i-PrOH 95/5, flow rate 0.6 mL/min, t R minor (2S,3R) = 22.59 min, t R major (2R,3S) = 25.07 min.
trans-(2R,3S)-Epoxy-3-(naphthyl)-1-phenyl-1-propan-1-one 35,40 (36j)
The ee of epoxide 36k was determined by HPLC analysis using a Chiralcel AD-H column View publication stats View publication stats
